TAFASITAMAB-CXIX for Diffuse large b-cell lymphoma recurrent: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 8 adverse event reports in the FDA FAERS database where TAFASITAMAB-CXIX was used for Diffuse large b-cell lymphoma recurrent.

Most Reported Side Effects for TAFASITAMAB-CXIX

Side Effect	Reports	%	Deaths	Hosp.
Disease progression	218	29.6%	41	8
Lymphoma	158	21.5%	3	7
Off label use	126	17.1%	7	20
Death	53	7.2%	53	3
Drug ineffective	39	5.3%	19	5
Blood lactate dehydrogenase increased	34	4.6%	14	0
Diffuse large b-cell lymphoma	32	4.4%	13	4
Malignant neoplasm progression	30	4.1%	5	3
Neutropenia	30	4.1%	5	7
Polyneuropathy	29	3.9%	0	8
Covid-19	28	3.8%	9	17
Cytopenia	25	3.4%	0	1
Ill-defined disorder	21	2.9%	0	1
Product use issue	21	2.9%	2	1
Neoplasm progression	20	2.7%	7	0